[go: up one dir, main page]

MX2017004662A - Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad. - Google Patents

Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad.

Info

Publication number
MX2017004662A
MX2017004662A MX2017004662A MX2017004662A MX2017004662A MX 2017004662 A MX2017004662 A MX 2017004662A MX 2017004662 A MX2017004662 A MX 2017004662A MX 2017004662 A MX2017004662 A MX 2017004662A MX 2017004662 A MX2017004662 A MX 2017004662A
Authority
MX
Mexico
Prior art keywords
animal
activity
frailty
treating
compositions
Prior art date
Application number
MX2017004662A
Other languages
English (en)
Inventor
Pan Yuanlong
R Jackson Janet
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2017004662A publication Critical patent/MX2017004662A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/42—Dry feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/45—Semi-moist feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)

Abstract

La presente invención proporciona un método para aumentar la movilidad o actividad en un animal o tratar la fragilidad en un animal; el método comprende identificar un animal con movilidad o actividad reducida o que tiene fragilidad y administrar una composición que comprende uno o más triglicéridos de cadena media (MCT) al animal en una cantidad terapéuticamente eficaz para aumentar la movilidad o actividad en el animal o tratar la fragilidad en el animal. Además, una composición alimenticia para puede comprender 15 % a aproximadamente 50 % de proteína, aproximadamente 5 % a aproximadamente 40 % de grasa, aproximadamente 5 % a aproximadamente 50 % de carbohidrato y aproximadamente 1 % a aproximadamente 40 % de uno o más triglicéridos de cadena media (MCT); en donde la composición tiene un contenido de humedad de aproximadamente 5 % a aproximadamente 20 %, y los MCT están presentes en una cantidad terapéuticamente eficaz para aumentar la movilidad o actividad en el animal o tratar la fragilidad en el animal.
MX2017004662A 2014-10-10 2015-10-09 Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad. MX2017004662A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462062283P 2014-10-10 2014-10-10
PCT/IB2015/057745 WO2016055981A1 (en) 2014-10-10 2015-10-09 Compositions and methods for enhancing mobility or activity or treating frailty

Publications (1)

Publication Number Publication Date
MX2017004662A true MX2017004662A (es) 2017-07-26

Family

ID=54337840

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017004662A MX2017004662A (es) 2014-10-10 2015-10-09 Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad.

Country Status (12)

Country Link
US (1) US20160101081A1 (es)
EP (1) EP3203857A1 (es)
JP (1) JP2017531651A (es)
CN (1) CN106793800A (es)
AU (1) AU2015329536A1 (es)
BR (1) BR112017007066A2 (es)
CA (1) CA2963350A1 (es)
CL (1) CL2017000873A1 (es)
CO (1) CO2017004276A2 (es)
MX (1) MX2017004662A (es)
RU (1) RU2017114438A (es)
WO (1) WO2016055981A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107484896A (zh) * 2017-07-01 2017-12-19 山东阳春羊奶乳业有限公司 一种用于山羊交配期的公山羊专用饲料及其制备方法
CN107373041A (zh) * 2017-07-01 2017-11-24 山东阳春羊奶乳业有限公司 一种幼龄山羊专用饲料及其制备方法和应用
US20190183832A1 (en) * 2017-12-20 2019-06-20 Michael Guarnieri Nutritional bolus for animals
US20210401738A1 (en) * 2018-11-14 2021-12-30 Agronomed Pharmaceuticals Llc Dietary supplement compositions
BR112021021015A2 (pt) * 2019-05-31 2021-12-14 Nestle Sa Mistura de nutrientes à base de triglicerídeos de cadeia média (tcm) para fornecer benefícios de saúde a animais
WO2023215815A1 (en) * 2022-05-05 2023-11-09 Dabdoub Atif Dietary macro/micronutritional compositions and applications thereof
US12090151B1 (en) 2023-05-12 2024-09-17 Michael Guarnieri Injectable sustained release buprenorphine formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2161784A1 (en) * 1993-04-30 1994-11-10 Mark L. Dreher Enhancing performance capacity by sparing muscle glycogen with medium chain fatty acids
US6729412B2 (en) * 2001-07-06 2004-05-04 Hitachi Koki Co., Ltd. Power tool driven by linear motor
US7595079B2 (en) * 2005-07-08 2009-09-29 Bomac Vets Plus, Inc. Nutritional conjunctive support therapy for recovery in animals following stress or illness
NZ569235A (en) * 2005-12-15 2011-12-22 Nestec Sa Compositions and methods for preserving brain function using medium chain triglycerides
JP5931337B2 (ja) * 2007-10-04 2016-06-08 ネステク ソシエテ アノニム 認知機能を高める組成物及び方法
JP5296366B2 (ja) * 2007-10-29 2013-09-25 日清オイリオグループ株式会社 医薬品用持久力向上剤および持久力向上用医薬品
EP2224930B1 (en) * 2008-01-04 2016-06-15 Nestec S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions
CN103442725A (zh) * 2011-01-25 2013-12-11 雀巢产品技术援助有限公司 治疗、减轻或预防动物的视觉系统衰退的方法和组合物
TWI572352B (zh) * 2012-03-01 2017-03-01 波麥堤克藥學Ｓｍｔ有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法

Also Published As

Publication number Publication date
AU2015329536A1 (en) 2017-04-06
RU2017114438A3 (es) 2019-02-22
BR112017007066A2 (pt) 2017-12-12
CO2017004276A2 (es) 2017-07-11
EP3203857A1 (en) 2017-08-16
WO2016055981A1 (en) 2016-04-14
US20160101081A1 (en) 2016-04-14
JP2017531651A (ja) 2017-10-26
CN106793800A (zh) 2017-05-31
RU2017114438A (ru) 2018-10-26
CA2963350A1 (en) 2016-04-14
CL2017000873A1 (es) 2017-10-30

Similar Documents

Publication Publication Date Title
MX2017004662A (es) Composiciones y metodos para mejorar la movilidad o actividad o tratar la fragilidad.
PH12018500810A1 (en) Antibody agents specific for human cd19 and uses thereof
BR112017000301A2 (pt) tratamento de leucemia com inibidores de histona desacetilase
SG10201907660YA (en) Use of short chain fatty acids in cancer prevention
MX2018014083A (es) Composiciones nutritivas para la proteccion cardiaca en animales de compañia.
BR112015031719A2 (pt) método para preparar aditivo de ração
MX2020009677A (es) Composiciones preparadas de aves de corral y metodos de su uso.
EA201691436A1 (ru) Композиция, включающая окру для применения в уменьшении абсорбции пищевого жира
MX2017006639A (es) Metodos y composiciones para preservar la masa corporal magra y promover la perdida de grasa durante la perdida de peso.
MX2023005014A (es) Metodos de tratamiento de enfermedades inflamatorias cronicas.
BR112017006770A2 (pt) composições farmacêuticas e alimentícias para induzir a satisfação e prolongar a saciedade em indivíduos que precisam do mesmo
MX394452B (es) Inhibicion de la actividad de olig2.
WO2017029558A3 (en) Methods for improving health of farmed fish
SG10201811078XA (en) Method Of Treatment Of Hypoxia Inducible Factor (HIF)-Related Conditions
MX2020001428A (es) Composiciones de grapiprant y metodos para usar las mismas.
PH12017500203A1 (en) Nutritional composition for use in promoting gut and/or liver maturation and/or repair
MX394015B (es) Inhibición de la actividad de la olig2.
CO2017001899A2 (es) Tratamiento del cáncer con el inhibidor de la alfa-amilasa en los animales de compañía
BR112018000252A2 (pt) métodos e composições farmacêuticas para intensificar atividades de eliminação de célula nk
MX384726B (es) Composición para el tratamiento de ectoparasitosis y la promoción del crecimiento en acuicultura.
MX391405B (es) Inhibidores de azepano de la interacción menina-mll.
MX2018012964A (es) Métodos y composiciones de uso para el tratamiento de la degeneración de tendón.
MX2017006638A (es) Metodos y composiciones para el incremento de la masa corporal magra y minimizar la ganancia de grasa corporal y el control del peso.
BR112016016842A2 (pt) Composição compreendendo um herbicida seletivo e um extrato de algas, uso de um extrato de algas para desintoxicar plantas submetidas ao tratamento com um herbicida seletivo
WO2019078634A3 (ko) Ptp4a1 단백질을 포함하는 인슐린 저항성 또는 지방간의 예방 또는 치료용 약학적 조성물